Top Markets
Coin of the day
Nika Pharmaceuticals Inc. Nika Pharmaceuticals Inc.

Nika Pharmaceuticals Inc.

NIKA
Rang in Aktien #14183
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in... Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
Aktienkurs
$0.41
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$429.91M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-56.72%
Land
US
Handel Nika Pharmaceuticals Inc. (NIKA)

Kategorie

Dividendenrendite-Verlauf für Nika Pharmaceuticals Inc. (NIKA)
Dividendenrendite (TTM) von Nika Pharmaceuticals Inc. (Aktienkürzel: NIKA) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Nika Pharmaceuticals Inc. (NIKA) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber